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1. General information
All aryl halides and boronic acids were used as received. All bases were used as received (in 
air) or dried under vacuum at 100 °C (under inert atmosphere). All solvents were used as 
received when experiments were conducted in air. Degassed solvents were used when 
experiments were conducted under inert atmosphere. All [NHC·H][Pd(R-allyl)Cl2] were 
prepared from commercially available NHC·HCl and [Pd(R-allyl)Cl]2.
Flash chromatography was performed on silica gel 60 Å pore diameter and 40-63 µm 
particles size.
1H, 19F{1H} and 13C{1H} Nuclear Magnetic Resonance (NMR) spectra were recorded on 
Bruker-400 and 500 MHz spectrometers at 298K in CDCl3, purchased from Acros and dried 
over molecular sieves. Chemical shifts (expressed in parts per million, ppm) are referenced 
to the residual solvent peak. Coupling constants, J, are given in hertz. Abbreviations used in 
the designation of the signals: s = singlet, d = doublet, dd = doublet of doublets, ddd = 
doublet of doublet of doublets, dt = doublet of triplets, t = triplet, td = triplet of doublets, m 
= multiplet, 
Elemental analyses were performed at London Metropolitan University 166-220 Holloway
Road, London, N7 8DB.
2. Synthesis of [NHC·H][Pd(ƞ3-R-allyl)Cl2] complexes
General procedure:
In air, the NHC·HCl and [Pd(ƞ3-R-allyl)(μ-Cl)]2 were added to a mortar. The two solids were mixed and 
grinded using a pestle for 5 min. A crystalline solid was obtained.
Synthesis of [IPr·H][Pd(ƞ3-cin)Cl2]1
Following the general procedure from IPr·HCl (82.1 mg, 0.19 mmol) and [Pd(ƞ3-cin)(μ-Cl)]2 (35.3 mg, 
0.09 mmol), the product was obtained as a yellow powder in 99% yield (117. mg).
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 9.19 (s, 1H, CNCHN), 8.32 (d, J = 1.6 Hz, 2H, CHImid),  7.54 (t, J = 
8.1 Hz, 2H, CHAr), 7.45 (dd, J = 6.1 Hz, 2H, CHAr(cin)), 7.33 (d, J = 7.9 Hz, 4H, CHAr), 7.21 (m, 3H, CHAr(cin)), 
5.69-5.62 (m, 1H, CH(cin)), 4.46 (m, 1H, CH2(cin)), 3.86 (d, J = 6.6 Hz, 1H, CH2(cin)), 2.90 (d, J = 11.9 Hz, 1H, 
CH(cin)), 2.48-2.41 (m, 4H, CH(IPr)), 1.27 (d, J = 6.8 Hz, 12H, CH3(IPr)), 1.19 (d, J = 6.7 Hz, 12H, CH3(IPr)).
13C {1H} NMR (400 MHz, CDCl3): δ (ppm) = δ 145.1 (CAr), 136.9 (CHNCN), 132.1 (CHAr), 129.9 (CAr), 128.7 
(CHcin), 127.9 (CHcin), 127.7 (CHimid), 124.7 (CH), 105.2 (CHcin), 81.8 (CHcin), 58.4 (CH2(cin)), 29.0 (CH(IPr)), 
24.7 (CH3(IPr)), 23.9 (CH3(IPr)). 
Anal. Calcd. for C36H46Cl2N2Pd: C 63.21, H 6.78, N 4.10. Found: C 63.11, H 6.95, N 4.14.
Synthesis of [IPent·H][Pd(ƞ3-cin)Cl2]1
Following the general procedure from IPent·HCl (62.2 mg, 0.12 mmol) and [Pd(ƞ3-cin)(μ-Cl)]2 (30. mg, 
0.06 mmol), the product was obtained as a yellow powder in 99% (92 mg).
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.43 (d, J = 1.6 Hz, 2H, CHImid), 8.37 (br. s, 1H, CNCHN), 7.60 (t, J 
= 7.9 Hz, 2H, CHAr), 7.50 (d, J = 7.5 Hz, 2H, CHAr(cin)), 7.27 (m, 7H, CHAr), 5.75 (br. s, 1H, CH(cin)), 4.60 (br. 
s, 1H, CH2(cin)), 3.93 (br. s, 1H, CH2(cin)), 3.00 (br. s, 1H, CH(cin)), 1.96 (sept, J = 8.1 Hz, 4H, CH(IPent)), 1.75-
1.60 (m, 16H, CH2(IPent)), 0.86 (t, J = 7.1 Hz, 12H, CH3(IPent)), 0.76 (t, J = 7.4 Hz, 12H, CH3(IPent)).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 142.7 (CAr), 134.9 (CHNCN), 132.8 (CAr), 132.0 (CHAr), 129.2 
(CHcin), 128.9 (CHcin), 128.3 (Ccin), 128.1 (CHimid), 125.4 (CHAr), 105.6 (CHcin), 81.2 (CHcin), 59.2 (CH2(cin)), 
43.5 (CH(IPent)), 29.4 (CH2(IPent)), 28.5 (CH2(IPent)), 12.6 (CH3(IPent)), 12.4 (CH3(IPent)).
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Anal. Calcd. for C44H62Cl2N2Pd·0.33CH2Cl2: C 64.57, H 7.66, N 3.40. Found: C 64.77, H 7.94, N 3.68. 
Traces of DCM in the final the compound proved highly difficult to completely remove.
Synthesis of [IPr*·H][Pd(ƞ3-cin)Cl2]1
Following the general procedure from IPr*·HCl (108.6 mg, 0.12 mmol) and [Pd(ƞ3-cin)(μ-Cl)]2 (30.0 
mg, 0.06 mmol), the product was obtained as a yellow powder in 99% yield (147.0 mg).
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 12.52 (s, 1H, CNCHN), 7.31-7.23 (m, 20H, CHAr), 7.19-7.06 (m, 
19H, CHAr), 6.77-6.75 (m, 10H, CHAr), 5.87-5.75 (br. m, 1H, CHcin), 5.41 (s, 4H, CHIPr), 5.33 (s, 2H, CHcin), 
4.60-3.85 (br. m, 2H, CHcin), 2.97-2.58 (m, 1H, CHcin), 2.18 (s, 6H, CH3).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 142.6 (CAr), 142.5 (CHNCN), 142.1 (CAr), 140.7 (CAr), 140.6 
(CAr), 130.7 (CHAr), 130.2 (CHAr), 129.1 (CHAr), 128.3 (CHAr), 127.9 (CHAr), 126.6 (CHAr), 126.5 (CHAr), 
122.8 (CHimid), 105.6 (CHcin), 82.2 (CHcin), 59.3 (CHcin), 51.0 (CH(IPr*)), 21.7(CH3(IPr*)).
Anal. Calcd. for C78H66Cl2N2Pd C 77.51, H 5.50, N 2.32; Found: C 77.25, H 5.47, N 2.36.
3. Optimization of the Buchwald-Hartwig Reaction
General procedure
In a glovebox, a vial was charged with the pre-catalyst, base, solvent (1 mL) and a magnetic 
stir bar and sealed with a screw cap. The mixture was let to stir at the 110 °C for the stated 
time (10 mins – 1 h, activation time). The sample was removed from the heating block and 
the corresponding aniline was added followed by the corresponding aryl chloride. The 
reaction was left stirring (910 rpm) for 16 h at varying temperatures.
3.1. Catalyst screening
The general procedure was followed using 4-fluoroaniline (61.1 mg, 0.55 mmol), 4-
chloroanisole (61 μL, 0.5 mmol) with KOtAm (69.8 mg, 0.55 mmol) in 1,4-dioxane (1 mL) with 
activation and experimental temperatures at 110 °C. 
Table S1: Optimisation of Pd pre-catalyst for 0.2 - 0.5% mol reaction
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
pre-catalyst 0.2-0.5 mol%
KOtAm (1.1 equiv.)
1,4-dioxane (1 mL)
110 oC, 16 h
MeO
H
N
F
Entries Pd pre-catalyst Mass 
(mg)
Catalyst loading
(mol%)
GC Conversiona,b (%)
1 [IPent·H][Pd(ƞ3-cin)Cl2] 2.0 0.5 86
2 [IHept·H][Pd(ƞ3-cin)Cl2] 2.3 0.5 88
3 [INon·H][Pd(ƞ3-cin)Cl2] 2.6 0.5 93 
4 [IPr*·H][Pd(ƞ3-cin)Cl2] 3.0 0.5 99
5 [Pr*OMe·H][Pd(ƞ3-cin)Cl2] 3.1 0.5 95
6 [IPentCl·H][Pd(ƞ3-cin)Cl2] 2.2 0.5 87
7 [IPr·H][Pd(ƞ3-cin)Cl2] 1.7 0.5 63
8 [IPr*·H][Pd(ƞ3-cin)Cl2] 3.0 0.5 99
9 [IPr*·H][Pd(ƞ3-crotyl)Cl2] 2.8 0.5 96
10 [IPr*·H][Pd(ƞ3-2-Me-allyl)Cl2] 2.8 0.5 95
11 [IPr*·H][Pd(IndtBu)Cl2] 3.2 0.5 87
12 [INon·H][Pd(ƞ3-cin)Cl2] 2.7 0.5 98 
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13 [IPr*·H][Pd(ƞ3-cin)Cl2] 1.2 0.2 99c
14 [IPr*·H][Pd(ƞ3-crotyl)Cl2] 1.2 0.2 90c
15 [IPr*·H][Pd(ƞ3-2-Me-allyl)Cl2] 1.2 0.2 88c
16 [IPr*·H][Pd(IndtBu)Cl2] 1.3 0.2 56c
17 [INon·H][Pd(ƞ3-cin)Cl2] 1.0 0.2 83c
a GC conversion based on 4-chloroanisole dissapearance. Value calculated from an average of two reactions. 
bGC yield, mesitylene is used as internal standard.c 0.2 mol% of catalyst used.
3.2. Activation time Optimization
The general procedure was followed using [IPr*·H][Pd(ƞ3-cin)Cl2] (0.5 mol%), 4-fluoroaniline 
(61.1 mg, 0.55 mmol), 4-chloroanisole (61 μL, 0.5 mmol) with KOtAm (69.8 mg, 0.55 mmol) 
in 1,4-dioxane at 110 °C with varying activation times. 
Table S2: Activation time optimization
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPr*H] 0.5 mol%
KO tAm (1.1 equiv.)
1,4-dioxane (1 mL)
110 oC, 16 h
MeO
H
N
F
Entries Time (min) GC conversion (%)a
1 10 88
2 30 80
3 60 99
a GC conversion is based on 4-chloroanisole. Value calculated from an average of two reactions.
3.3. Temperature optimization
The general procedure was followed using pre-catalyst (0.5 ml%), 4-fluoroaniline (61.1 mg, 
0.55 mmol), 4-chloroanisole (61 μL, 0.5 mmol) with KOtAm (69.8 mg, 0.55 mmol) in 1,4-
dioxane at with varying activation temperatures for 1 h and varying experimental 
temperature. 
Table S3: Temperature optimisation using [IPr*·H][Pd(ƞ3-cin)Cl2] 
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPrH] 0.5 mol%
KO tAm (1.1 equiv.)
1,4-dioxane (1 mL)
60-100 oC, 16 h
MeO
H
N
F
Entries Activation 
Temperature (°C)
Reaction Temperature
(°C)
GC conversion (%)a
1 60 60 83
2 70 70 80
3 80 80 92
4 90 90 85
5 70 100 76
6 80 100 85
7 90 100 90
8 100 100 95
a GC conversion is based on 4-chloroanisole. Value calculated from an average of two reactions
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Table S4: Temperature optimisation using [IPr*·H][Pd(ƞ3-cin)Cl2]
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPrH] 0.5 mol%
KO tAm (1.1 equiv.)
1,4-dioxane (1 mL)
60-100 oC, 16 h
MeO
H
N
F
Entries Activation 
Temperature (°C)
Reaction Temperature 
(°C)
GC conversion (%)a
1 60 80 99
2 80 80 90
2 90 90 88
a GC conversion is based on 4-chloroanisole. Value calculated from an average of two reactions
3.4. Solvent Optimization
The general procedure was followed using [IPr*·H][Pd(ƞ3-cin)Cl2] (0.5 ml%), 4-fluoroaniline 
(61.1 mg, 0.55 mmol), 4-chloroanisole (61 μL, 0.5 mmol) with KOtAm (69.8 mg, 0.55 mmol) 
in varying solvents, activating at 80 °C for 1 h and running at 80 °C for 16h. 
Table S5: Solvents used in solvent optimisation in air
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPr*H] 0.5 mol%
KO tAm (1.1 equiv.)
1,4-dioxane (1 mL)
80 oC, 16 h
MeO
H
N
F
Entries Solvent GC conversion (%)a
1 Toluene 80
2 THF 64
3 Ethanol n.r.
4 iso-Propanol n.r.
5 n-Butanol n.r.
6 1,4-Dioxane 93
a GC conversion based on 4-chloroanisole. Value calculated from an average of two reactions. n.r. = no 
reaction.
Table S6: Solvents used in solvent optimization under inert atmosphere
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPr*H] 0.5 mol%
KO tAm (1.1 equiv.)
1,4-dioxane (1 mL)
80 oC, 16 h
MeO
H
N
F
Entries Solvent GC conversion (%)a
1 Toluene 90
2 THF 92
3 iso-Propanol 19
4 Acetonitrile n.r.
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5 Hexane 89
6 1,2-Dimethoxyethane 90
7 1,4-Dioxane 90
8 Cyclohexane 94
9 CPME 97
10 2-MeTHF 87
11 Heptane 87
12 1,4-Dioxaneb 97
13 THFb 99
14 CPMEb 96
15 Cyclohexaneb 94
16 Ethanolc n.r.
a GC conversion based on 4-chloroanisole. Value calculated from an average of two reactions. b The substrates 
were added in reverse order; 4-fluoroaniline followed by 4-chloroanisole. c K2CO3 as the base.
3.5. Base Optimization
The general procedure was followed using [IPr*·H][Pd(ƞ3-cin)Cl2] (0.5 mol%), 4-fluoroaniline 
(61.1 mg, 0.55 mmol), 4-chloroanisole (61 μL, 0.5 mmol) with the corresponding base (0.55 
mmol) and corresponding solvent (1 mL), activating at 80 °C for 1 h and running at 80 °C for 
16h.  
Table S7: Base optimization in 1,4-dioxane
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPr*H] 0.5 mol%
Base (1.1 equiv.)
Solvent (1 mL)
80 oC, 16 h
MeO
H
N
F
Entries Base (0.55 mmol) GC conversion (%)a
1 KOtBu 93
2 K2CO3 n.r.
3 K3PO4 n.r.
4 KOH 57
5 NaOH 45
6 Cs2CO3 <1
7 LiOH n.r.
8 CsOH 22
9 Na2CO3 n.r.
10 NaOtBu 91
11 KF/K2CO3 (1:1) n.r.
12 KOtBub 83
a GC conversion based on 4-chloroanisole. Value calculated from an average of two reactions. b The substrates 
were added in reverse order; 4-fluoroaniline followed by 4-chloroanisole.
Table S8: Base optimization in THF
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPr*H] 0.5 mol%
Base (1.1 equiv.)
Solvent (1 mL)
80 oC, 16 h
MeO
H
N
F
Entries Base (0.55 mmol) GC conversion (%)a
S9
1 KOtAm 92
2 KOtBu 98
3 K2CO3 n.r.
4 K3PO4 n.r.
5 KOH 57
6 NaOH 19
7 Cs2CO3 7
8 LiOH n.r.
9 CsOH 22
10 Na2CO3 n.r.
11 KOtBu 99
a GC conversion based on 4-chloroanisole. Value calculated from an average of two reactions.
Table S9: Base optimization in cyclohexane
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPr*H] 0.5 mol%
Base (1.1 equiv.)
Solvent (1 mL)
80 oC, 16 h
MeO
H
N
F
Entries Base (0.55 mmol) GC conversion (%)a
1 KOtAm 94
2 KOtBu 86
3 KOH 12
4 NaOH <1
5 CsOH n.r.
a GC conversion based on 4-chloroanisole. Value calculated from an average of two reactions.
Table S10: Base optimization in CPME
MeO
Cl
F
NH2
0.5 mmol 1 equiv.
+
[Pd(3-cinnamyl)Cl2][IPr*H] 0.5 mol%
Base (1.1 equiv.)
Solvent (1 mL)
80 oC, 16 h
MeO
H
N
F
Entries Base (0.55 mmol) GC Conversion (%)a
1 KOtAm 99
2 KOtBu 99
3 KOH 42
4 NaOH 32
5 CsOH 38
6 NaOtBu 98
a GC conversion based on 4-chloroanisole. Value calculated from an average of two reactions.
3.6. Catalyst loading optimization
The general procedure was followed using [IPr*·H][Pd(ƞ3-cin)Cl2] (mol%), 4-fluoroaniline (61.00 mg, 
0.55 mmol), 4-chloroanisole (61.00 μL, 0.50 mmol) with KOtBu (62.00 mg, 0.55 mmol) in CPME (2 
mL), activating at 60 °C for 1 h and running at 80 °C for 16 h. An aliquot was taken to determine the 
conversion of 4-chloroanisole by GC using mesitylene as internal standard.
Table S11: Catalyst loading optimization
Entries mol% GC yield (%)a
S10
1 0.5 99
2 0.5b 70
3 0.3 99
4 0.2 99
5 0.1 50
aGC yield, internal standard = mesitylene 0.1 mmol. Value calculated from an average of two reactions. bno 
activation step was used.
3.7. Reaction time optimization
The general procedure was followed using [IPr*H][Pd(ƞ3-cin)Cl2] (0.20 mol%), 4-fluoroaniline (61 mg, 
0.55 mmol), 4-chloroanisole (61 μL, 0.50 mmol) with KOtBu (62.00 mg, 0.55 mmol) in CPME (2 mL), 
activating at 60 °C for 1 h and running at 80 °C for the corresponding time. An aliquot was taken to 
determine the conversion of 4-chloroanisole by GC using mesitylene as internal standard.
Table S12: Time optimization
Activation time (min) Reaction time (min) GC yield (%)
60 15 30
60 30 34
60 45 43
60 60 75
60 90 83
60 120 99
GC yield, internal standard = mesitylene 0.10 mmol. Value calculated from an average of two reactions.
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Figure S1: Time optimization of the Buchwald-Hartwig amination. GC yield, internal standard = 
mesitylene 0.1mmol. Value calculated from an average of two reactions. 
4. Buchwald-Hartwig reaction scope
General procedure
A vial was charged with [IPr*H][Pd(ƞ3-cin)Cl2] (1.2 mg, 0.2 mol%), KOtBu (62 mg, 0.55 mmol), 
CPME (1 mL) and a magnetic stir bar and sealed with a screw cap. The mixture was let to stir 
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at 60 °C for 1 h. The vial was removed from the heating block and the corresponding 
solution of aniline and aryl chloride in CPME (1 mL) was added. The reaction was left to stir 
(910 rpm) for 2 h at 80 °C. The crude mixture was purified by a filtration through silica gel.
Compound 4a
H
N
MeO F
Chemical Formula: C13H12FNO
Molecular Weight: 217.24
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and 4-
fluoroaniline (56 mg, 0.55 mmol), the product yielded 107 mg (99 %) as an oil.
Large scale:
Following the general procedure, from 4-chloroanisole (784 mg, 5.5 mmol) and 4-
fluoroaniline (672 mg, 6.05 mmol), the product yielded 1193 mg (99 %) as an oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.02 (dt, J = 9.1 Hz, 2H), 6.95 (m, 6H), 5.38 (s, 1H), 
3.80 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 157.2 (d, CF, J = 238.1), 155.1 (C), 141.2 (d, C, J 
= 1.9 Hz), 136.6 (C), 121.3 (CH), 117.9 (d, CH, 7.6 Hz), 117.9 (CH), 115.9 (d, CH, J = 22.4 Hz), 
114.9 (CH), 55.7 (CH3).
Analytical data obtained were in agreement with the reported values.2
Compound 4b
H
N F
Chemical Formula: C13H12FN
Molecular Weight: 201.24
Following the general procedure, from 3-chlorotoluene (63 mg, 0.5 mmol) and 3-
fluoroaniline (56 mg, 0.55 mmol), the product yielded 99.8  mg (99 %) as an oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.25 (m, 2H), 6.97 (m, 2H), 6.89 (d, J = 8.7 Hz, 1H), 
6.81 (m, 2H), 6.65 (t, J = 7.1 Hz, 1H), 5.74 (s, 1H), 2.38 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 1632.9 (d, CF, J = 243.8 Hz), 145.6 (d, C, 10.55 
Hz), 142.0 (C), 139.5 (C), 130.5 (d, CH, J = 10.0 Hz), 129.4 (CH), 123.1 (CH), 119.9 (CH), 116.2 
(CH), 112.6 (CH), 107.0 (d, CH, J = 21.5 Hz), 103.6 (d, CH, J = 25.1 Hz), 21.6 (CH3).
Analytical data obtained were in agreement with the reported values.3
Compound 4c
H
N
OMe
F
Chemical Formula: C13H12FNO
Molecular Weight: 217.24
Following the general procedure, from 2-chloroanisole (72 mg, 0.5 mmol) and 2-
fluoroaniline (56 mg, 0.55 mmol), the product yielded 86 mg (80 %) as an oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = 7.43 (td, J = 8.3, 1.5 Hz, 1H), 7.31-7.29 (m, 1H), 7.13 
(ddd, J = 11.3, 8.1, 1.4 Hz, 1H), 7.07 (t, J = 7.7 Hz, 1H), 6.93-6.86 (m, 4H), 6.23 (s, 1H), 3.91 (s, 
3H).
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13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 153.7 (d, CF, J = 241.7 Hz), 149.0 (C), 132.0 (C), 
131.4 (d, C, J = 11 Hz), 124.3 (d, CH, J = 3.6 Hz), 120.9 (d, CH, J = 7.0 Hz), 120.8 (d, CH, J = 
8.1), 118.1 (2CH), 115.6 (d, CH, J = 19.4 Hz), 115.5 (CH), 110.7 (CH), 55.7 (CH3).
Analytical data obtained were in agreement with the reported values.4
Compound 4d
H
N
OMe
Chemical Formula: C14H15NO
Molecular Weight: 213.28
Following the general procedure, from 4-chlorotoluene (63 mg, 0.5 mmol) and 4-
methoxyaniline (68 mg, 0.55 mmol), the product yielded 105 mg (99 %) as a black powder.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.66 (m, 4H), 6.88 (m, 4H), 5.41 (s, 1H), 3.80 (s, 3H), 
2.29 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 154.6 (C), 142.2 (C), 136.5 (C), 129.6 (C), 129.2 
(CH), 120.9 (CH), 116.4 (CH), 114.5 (CH), 55.4 (CH3), 20.4 (CH3).
Analytical data obtained were in agreement with the reported values.5
Compound 4e
H
NMeO
OMe
OMe
Chemical Formula: C15H17NO3
Molecular Weight: 259.31
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and 3,5-
dimethoxyaniline (67 mg, 0.55 mmol), the product yielded 122.7 mg (95 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.10 (d, J = 9.2 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 6.07 
(m, 3H), 5.52 (br. s, 1H), 3.80 (m 9H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 171.2 (C), 161.3 (C), 155.5 (C), 148.5 (C), 147.4 
(C), 135.2 (CH), 123.0 (CH), 114.6 (CH), 93.8 (CH), 93.7 (CH), 91.6 (CH), 90.9 (CH), 60.4 (CH3), 
55.5 (CH3), 55.1 (CH3).
Analytical data obtained were in agreement with the reported values.6
Compound 4f
N
H
N Chemical Formula: C13H14N2
Molecular Weight: 198.27
Following the general procedure, from 2-chloropyridine (57 mg, 0.5 mmol) and 3,5-
dimethylaniline (67 mg, 0.55 mmol), the product yielded 74.5 mg (75 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = 8.22 (s, 1H), 7.53 (m, 1H), 6.96 (m, 3H), 6.77 (br. s, 1H), 
6.75 (m, 2H), 2.34 (s, 6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 156.3 (C), 148.4 (CH), 140.4 (C), 139.1 (CH), 
137.9 (C), 125.0 (CH), 118.5 (CH), 114.9 (CH), 108.3 (CH), 221.5 (CH3).
Analytical data obtained were in agreement with the reported values.7
Compound 4g
S13
MeO
H
N Chemical Formula: C14H15NO
Molecular Weight: 213.28
Following the general procedure, from 4-chloroanisole (63 mg, 0.5 mmol) and o-toluidine 
(59 mg, 0.55 mmol), the product yielded 106 mg (99 %) as a oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.20 (d, J = 8.2 Hz, 1H), 7.14 (t, J= 8.3 Hz, 1H), 7.07 
(m, 3H), 6.92 (m, 3H), 5.25 (s, 1H), 3.84 (s, 3H), 2.29 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 155.2 (C), 143.4 (C), 136.4 (C), 130.8 (C), 126.9 
(CH), 125.4 (CH), 122.2 (CH), 120.1 (CH), 115.2 (CH), 114.8 (CH), 55.7 (CH3), 17.9 (CH3).
Analytical data obtained were in agreement with the reported values.5
Compound 4h
MeO
H
N Chemical Formula: C16H19NO
Molecular Weight: 241.33
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and 2-
isopropylaniline (75 mg, 0.55 mmol), the product yielded 120 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.20 (d, J = 7.5 Hz, 1H), 7.03-6.98 (m, 2H), 6.89 (m, 
3H), 6.79 (m, 2H), 5.22 (br. s, 1H), 3.72 (s, 3H), 3.05 (sept, J = 6.8 Hz, 1H), 1.22 (dd, J = 5.2 Hz, 
6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 154.8 (C), 141.8 (C), 137.6 (C), 137.3 (C), 126.5 
(CH), 125.9 (CH), 121.4 (CH), 121.1 (CH), 118.1 (CH), 114.8 (CH), 55.7 (CH3), 27.6 (CH), 22.9 
(CH3), 22.4 (CH3).
Analytical data obtained were in agreement with the reported values.8
Compound 4i
N
H
Chemical Formula: C16H19N
Molecular Weight: 225.34
Following the general procedure, from 2-chloroanisole (63 mg, 0.5 mmol) and 2-
iospropylaniline (71 mg, 0.55 mmol), the product yielded 111.9 mg (99 %) as a beige solid.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.33 (d, J = 8.4 Hz, 1H), 7.21 (d, J = 7.2 Hz, 1H), 7.16-
7.05 (m, 4H), 6.93 (m, 2H), 5.24 (s, 1H), 3.17 (q, J = 5.8 Hz, 1H), 2.29 (s, 3H), 1.29 (d, J = 7.0 
Hz, 6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 143.2 (C), 140.4 (C), 139.5 (C), 130.8 (CH), 127.0 
(C), 126.6 (CH), 126.5 (CH), 126.1 (CH), 122.8 (CH), 121.0 (CH), 120.7 (CH), 119.1 (CH), 117.0 
(CH), 27.9 (CH), 23.1 (CH3), 17.9 (CH3).
Analytical data obtained were in agreement with the reported values.8
Compound 4j
H
N Chemical Formula: C15H17N
Molecular Weight: 211.31
S14
Following the general procedure, from 4-chlorotoluene (63 mg, 0.5 mmol) and 2,6-
dimethylaniline (67 mg, 0.55 mmol), the product yielded 104 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.14-7.08 (m, 3H), 7.00 (d, J = 7.8 Hz, 2H); 6.46 (d, J = 
7.9 Hz, 2H), 5.11 (s, 1H), 2.26 (s, 3H), 2.23 (s, 6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 144.0 (C), 138.8 (C), 135.6 (C), 129.8 (CH), 128.6 
(CH), 127.5 (C), 125.5 (CH), 113.9 (CH), 20.6 (CH3), 18.5 (CH3).
Analytical data obtained were in agreement with the reported values.8
Compound 4k
MeO
H
N Chemical Formula: C15H17NO
Molecular Weight: 227.31
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and 2,6-
dimethylaniline (67 mg, 0.55 mmol), the product yielded 112 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.12 (d, J = 7.1 Hz, 2H), 7.16 (m, 1H), 6.76 (d, J = 8.5 
Hz, 2H). 6.51 (d, J = 9.4 HZ, 2H), 5.03 (s, 1H), 3.75 (s, 3H), 2.20 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 152.8 (C), 140.2 (C), 139.4 (C), 135.0 (C), 128.7 
(CH), 128.3 (CH), 125.0 (CH), 121.8 (CH), 118.1 (CH), 115.3 (CH), 114.8 (CH), 55.9 (CH3), 18.5 
(CH3).
Analytical data obtained were in agreement with the reported values.5
Compound 4l
OMe H
N
Chemical Formula: C15H17NO
Molecular Weight: 227.31
Following the general procedure, from 2-chloroanisole (71 mg, 0.5 mmol) and 2,6-
dimethylaniline (67 mg, 0.55 mmol), the product yielded 91 mg (80 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.13 (m, 3H), 6.87 (m, 1H), 6.70 (m, 2H), 6.14 (m, 
1H), 5.65 (s, 1H), 3.95 (s, 3H), 2.21 (s, 6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 146.9 (C), 138.5 (C), 136.3 (C), 136.1 (C), 128.6 
(CH), 125.8 (CH), 121.2 (CH), 117.4 (CH), 111.2 (CH), 110.(CH), 55.8 (CH3), 18.4 (CH3). 
Analytical data obtained were in agreement with the reported values.9
Compound 4m
N
H
N Chemical Formula: C13H14N2
Molecular Weight: 198.27
Following the general procedure, from 2-chloropyridine (57 mg, 0.5 mmol) and 2,6-
dimethylaniline (67 mg, 0.55 mmol), the product yielded 72 mg (73%) as a beige solid.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.15 (m, 1H), 7.35 (td, J = 6.7 Hz, 1H), 7.13 (s, 3H), 
6.64 (t, J =6.5 Hz, 1H), 6.27 (br. s, 1H), 6.01 (dt, J = 8.5 Hz, 1H), 2.23 (s, 6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 157.9 (C), 148.6 (CH), 138.0 (C), 136.9 (CH), 
136.6(C), 128.7 (C), 126.9 (CH), 113.8 (CH), 105.8 (CH), 18.5 (CH3).
S15
Analytical data obtained were in agreement with the reported values.5
Compound 4n
OMe
H
N Chemical Formula: C19H25NO
Molecular Weight: 283.42
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and o-toluidine 
(59 mg, 0.55 mmol), the product yielded 142 mg (99%) as a oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.39 (m, 1H), 7.31 (m, 2H), 7.14 (t, J = 8.1 Hz, 1H), 
6.37 (dd, J = 8.1 Hz, 1H), 6.21 (dd, J = 8.0 Hz, 1H), 6.12 (t, J = 2.0 Hz, 1H), 5.23 (s, 1H), 3.78 (s, 
3H), 3.34 (q, J = 7.2 Hz, 2H), 1.25 (d, J = 6.9 Hz, 12H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 160.9 (C), 149.7 (C), 147.7 (C), 135.1 (C), 130.0 
(CH), 127.4 (CH), 123.9 (CH), 106.2 (CH), 103.2 (CH), 99.1 (CH), 55.1 (CH3), 28.3 (CH), 24.0 
(CH3).
Analytical data obtained were in agreement with the reported values.5
Compound 4o
MeO
H
N Chemical Formula: C17H21NO
Molecular Weight: 255.36
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and 2,6-
diethylaniline (75 mg, 0.55 mmol), the product yielded 126 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.17 (m, 3H), 6.76 (dt, J = 9.1 Hz, 2H), 6.49 (dt, J = 8.5 
Hz, 2H), 5.01 (s, 1H), 3.77 (s, 3H), 2.61-2.56 (q, J = 7.5 Hz, 4H), 1.18 (t, J = 6.3 Hz, 6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 152.6 (C), 141.6 (C), 141.3 (C), 136.0 (C), 126.8 
(CH), 126.0 (CH), 114.9 (CH), 114.8 (CH), 55.7 (CH3), 24.8 (CH2), 14.8 (CH3).
Analytical data obtained were in agreement with the reported values.8
Compound 5a
N
N
Chemical Formula: C12H12N2
Molecular Weight: 184.24
Following the general procedure, from 4-chloropyridine (57 mg, 0.5 mmol) and N-methyl 
aniline (59 mg, 0.55 mmol), the product yielded 89.5 mg (99 %) as a yellow oil.
Large scale:
Following the general procedure, from 4-chloropyridine (624.5 mg, 5.5 mmol) and N-methyl 
aniline (648.3 mg, 6.05 mmol), the product yielded 1013 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.24 (m, 1H), 7.42 (t, J = 6.5 Hz, 2H), 7.31-1.22 (m, 
4H), 6.62 (m, 1H), 6.55 (m, 1H), 3.48 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 158.9 (C), 147.9 (C), 146.9 (CH), 136.6 (CH), 
129.8 (CH), 129.2 (CH), 126.4 (CH), 125.5 (CH), 113.2 (CH), 112.5 (CH), 109.2 (CH), 38.2 (CH3).
Analytical data obtained were in agreement with the reported values.2
S16
Compound 5b
MeO
N Chemical Formula: C14H15NO
Molecular Weight: 213.28
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and N-methyl 
aniline (59 mg, 0.55 mmol), the product yielded 106 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.23 (t, J = 7.9 Hz, 2H), 7.11 (d, J = 9.1 Hz, 2H), 6.91 
(d, J = 9.6 Hz, 2H), 6.81 (m, 3H), 3.82 (s, 3H), 3.27 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 156.4 (C), 149.8 (C), 142.3 (C), 129.3 (CH), 129.0 
(CH), 126.3 (CH), 118.4 (CH), 115.8 (CH), 114.8 (CH), 114.7 (CH), 112.4 (CH), 55.5 (CH3), 40.5 
(CH3).
Analytical data obtained were in agreement with the reported values.2
Compound 5c
N
F3C
Chemical Formula: C14H12F3N
Molecular Weight: 251.25
Following the general procedure, from 4-chlorobenzotrifluoride (90 mg, 0.5 mmol) and N-
methyl aniline (59 mg, 0.55 mmol), the product yielded 123.9 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.44 (m, 4H), 7.21(m, 3H), 6.86 (d, J = 8.9 Hz, 2H), 
3.35 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 151.6 (C), 147.8 (C), 129.9 (CH), 126.3 (dd, CH, J 
= 3.6, 7.6 Hz), 125.4 (CH), 125.1 (CH), 125.1 (q, CF3, J = 270.5 Hz), 120.1 (q, C-CF3, J = 32.6 
Hz), 114.9 (CH), 40.2 (CH3).
Analytical data obtained were in agreement with the reported values.3
Compound 5d
MeO
N
Chemical Formula: C15H25NO
Molecular Weight: 235.3710
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and dibutylamine 
(71 mg, 0.55 mmol), the product yielded 100 mg (80 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 6.83-6.81 (m, 2H), 6.67-6.65 (m, 2H), 3.76 (s, 3H), 
3.20 (t, J = 7.1 Hz, 4H), 1.56-1.48 (q, J = 7.7 Hz, 4H), 1.38-1.29 (sep, J = 8.4 Hz, 4H), 0.95 (t, J = 
7.2 Hz, 6H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 151.1 (C), 143.5 (C), 115.0 (CH), 114.5 (CH), 56.0 
(CH3), 51.8 (CH2), 29.6 (CH2), 20.6 (CH2), 14.2 (CH3).
Analytical data obtained were in agreement with the reported values.8
Compound 5e
S17
OMe
N
O
Chemical Formula: C11H15NO2
Molecular Weight: 193.25
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and morpholine 
(107 mg, 0.55 mmol), the product yielded 96 mg (99 %) as a white solid.
Large scale:
Following the general procedure, from 4-chloroanisole (784 mg, 5.5 mmol) and morpholine 
(1175.4 mg, 6.05 mmol), the product yielded 1061 mg (99 %) as a white solid.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 6.91-6.84 (m, 4H), 3.87-3.77 (m, 4H), 3.77 (s, 3H), 
3.07 (m, 4H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 154.1 (C), 145.8 (C), 118.0 (CH), 114.6 (CH), 67.2 
(CH2), 55.7 (CH3), 51.0 (CH2)
Analytical data obtained were in agreement with the reported values.2
Compound 5f
N
O
Chemical Formula: C11H15NO
Molecular Weight: 177.25
Following the general procedure, from 4-chlorotoluene (63 mg, 0.5 mmol) and morpholine 
(107 mg, 0.55 mmol), the product yielded 86 mg (97 %) as a white solid.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.10 (d, J = 8.73 Hz, 2H), 6.85 (d, J = 7.79 Hz, 2H), 
3.87 (m, 4H), 3.12 (m, 4H), 2.28 (s, 3H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 149.9 (C), 129.9 (C), 129.7 (CH), 116.2 (CH), 67.1 
(CH2), 50.1 (CH2), 20.6 (CH3).
Analytical data obtained were in agreement with the reported values.8
Compound 5g
 
N
MeO
Chemical Formula: C13H19NO
Molecular Weight: 205.30
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and 
Hexamethyleneimine (55 mg, 0.55 mmol), the product yielded 103 mg (99 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 6.84 (dt, J = 9.2 Hz, 2H), 6.66 (bd, J = 8.4 Hz, 2H), 3.76 
(s, 3H), 3.43 (t, J = 7.9 Hz, 4H), 1.78 (m, 4H), 1.56 (m, 4H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 150.5 (C), 143.9 (C), 115.1 (CH), 112.4 (CH), 56.0 
(CH3), 49.7 (CH2), 28.1 (CH2), 27.3 (CH2).
Analytical data obtained were in agreement with the reported values.10
Compound 5h
N
Chemical Formula: C13H19N
Molecular Weight: 189.30
S18
Following the general procedure, from 2-chloropyridine (57 mg, 0.5 mmol) and 
Hexamethyleneimine (55 mg, 0.55 mmol), the product yielded 94 mg (99 %) as a beige solid.
1H NMR (400 MHz, CDCl3): δ (ppm) = 7.16 (m, 2H), 7.07 (dd, J = 6.5 Hz, 1H), 6.94 (td, J = 12.6 
Hz, 1H), 3.10 (t, J = 5.5 Hz, 4H), 2.33 (s, 3H), 1.78 (m, 8H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 155.0 (C), 133.0 (C), 131.0 (CH), 126.5 (CH), 
122.4 (CH), 120.9 (CH), 56.0 (CH2), 29.7 (CH2), 27.1 (CH2), 19.0 (CH3).
Analytical data obtained were in agreement with the reported values.11
Compound 5i
MeO
N
Chemical Formula: C11H15NO
Molecular Weight: 177.25
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and pyrrolidine 
(67 mg, 0.55 mmol), the product yielded  71 mg (80 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 6.90 (dt, J = 8.7 Hz, 2H), 6.59 (dt, J = 9.5 Hz, 2H), 3.79 
(s, 3H), 3.29 (m, 4H), 2.04 (m, 4H).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 150.8 (C), 143.3 (C), 115.1 (CH), 112.7 (CH), 56.0 
(CH3), 48.3 (CH2), 25.2 (CH2).
Analytical data obtained were in agreement with the reported values.5
5. Synthesis of coupling substrates
N
O
+
N
O
O Ethanol, NaOH in H2O
X
X
X=Cl, Br X=Cl, 95%
Br, 93%
24 hours, RT
Scheme S1: Synthesis of starting materials 6a-b
General procedure: In a round bottom flask, N-ethylacetoindole (1.00 g, 5.34 mmol), and the 
corresponding aldehyde (8.00 mmol, 1.50 equiv.) were dissolved in ethanol (20 mL). Then, NaOH 
(853.00 mg, 16.00 mmol, 4.00 equiv.) in 10 ml water was added and the mixture was stirred at room 
temperature for 24 hours. The solid was then collected by filtration and washed with hexane to give 
the pure product.
N
O X X=Cl, 95%Br, 93%
H7
H1
H2
H3
H4 H6
H6
H5
H5
H8
H9
H10
H10 H11
H11
H5
(E)-3-(4-chlorophenyl)-1-(1-ethyl-1H-indol-3-yl)prop-2-en-1-one: Following the general 
procedure using 4-chloroaldehyde (1.12 g, 8.00 mmol) the product was obtained in 95% 
(1.56 g) yield. Melting point: 118 – 119 °C. 1H NMR (400 MHz, CDCl3): δ (ppm) = 8.54-8.51 
(m, 1H, H1), 7.91 (s, 1H, H7), 7.76 (d, J = 15.6 Hz, 1H, H4), 7.56 (d, J = 7.7 Hz, 2H, H8,9), 7.37 (m, 
6H, H2,3,10,11), 4.23 (m, 2H, H6), 1.57 (t, J = 7.2 Hz, 3H, H5) 13C {1H} NMR (100 MHz, CDCl3): δ 
(ppm) = δ 184.0 (C=O), 139.6 (C=C), 136.9 (C-N), 135.7 (CAr), 134.1 (CAr), 133.9 (CAr), 129.4 
S19
(CHAr), 129.2 (CHAr), 127.1 (CHN), 124.5 (CHAr), 123.7 (CHAr), 123.2 (CHAr), 122.9 (CHAr), 117.8 
(CHAr), 42.0 (CH2), 15.3 (CH3). IR (KBr, cm-1) νmax= 3046, 2971, 2926, 1653, 1595, 1527, 1480, 
1464, 1392, 1238, 1200, 1145, 1098, 1089, 1057, 967, 939, 856, 811, 750, 701, 426. 
Elemental analysis: Expected C, 73.66; H, 5.21; N, 4.52; Found: C, 73.75; H, 5.42; N, 4.39]. 
LC/MS (ESI, m/z): [M+], found 309.10, C19H16ClNO for 309.09.
(E)-3-(4-bromophenyl)-1-(1-ethyl-1H-indol-3-yl)prop-2-en-1-one: Following the general 
procedure using 4-bromoaldehyde (1.48 g, 8.00 mmol) the product was obtained in 93% 
(1.75 g) yield. Melting point: 139 – 140 °C. 1H NMR (400 MHz, CDCl3): δ (ppm) = 8.54-8.52 
(m, 1H, H1), 7.93 (s, 1H, H7), 7.74 (d, J = 15.6 Hz, 1H, H4), 7.53 (d, J = 7.7 Hz, 2H, H8,9), 7.40 (m, 
6H, H2,3,10,11), 4.28 (m, 2H, H6), 1.57 (t, J = 7.2 Hz, 3H, H5) 13C {1H} NMR (100 MHz, CDCl3): δ 
(ppm) = δ 184.0 (C=O), 139.6 (C=C), 136.9 (C-N), 135.7 (CAr), 134.1 (CAr), 133.9 (CAr), 129.4 
(CHAr), 129.2 (CHAr), 127.1 (CHN), 124.5 (CHAr), 123.7 (CHAr), 123.2 (CHAr), 122.9 (CHAr), 117.8 
(CHAr), 42.0 (CH2), 15.3 (CH3).IR (KBr, cm-1) νmax= 3049, 2977, 1646, 1611, 1588, 1524, 1463, 
1449, 1391, 1311, 1268, 1260, 1089, 1062, 993, 975, 858, 835, 779, 741, 717, 671, 561, 520, 
478. Elemental Analysis Expected: C 64.42, H 4.55, N 3.95. Found: C 64.31, H 4.67, N 4.15 
LC/MS (ESI, m/z): [M+], found 353.00, C19H16BrNO for 353.04.
C-N amination procedure:  A vial was charged with [IPr*·H][Pd(ƞ3-cin)Cl2] (12.0 mg, 2.0 mol%), 
KOtBu (11.2 mg, 0.10 mmol), CPME (0.2 mL) and a magnetic stir bar and sealed with a screw cap. The 
mixture was left to stir at the 60 °C for 1 h. The vial was removed from the heating block and the 
corresponding solution of aniline and aryl chloride in CPME (0.5 mL) was added. The reaction was 
left to stir (910 rpm) at 80 °C for 20 h. The reaction was purified using flash column chromatography, 
gradient from 10:90 to 50:50 ethyl acetate/petroleum ether.
Compounds 7a and 7b 
N
O
NH14
O
H1
H2
H3
H4 H5
H5
H6H6 H6
H7
H8
H9
H10
H13
H11
H12
H18
H16
H17
H15
C
H19
H19
H19
Following the general procedure, from N-Et-Indenone (17.6 mg, 0.05 mmol) and 4-methoxyaniline 
(6.8 mg, 0.05 mmol), the product was obtained in 80% yield (15.6 mg) as an orange/brown oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.53 (m, 1H1), 7.91 (s, 1H7), 7.79 (d, J = 15.5 Hz, 1H9), 7.53 (d, 
J = 8.6 Hz, 2H11 and 12), 7.39 (m, 1H2), 7.33 (m, 2H10 and 13), 7.29-7.24 (m, 2H3 and 4), 7.14 (d, J = 8.9 Hz, 
2H15 and 17), 6.91 (m, 3H8, 16 and 18), 5.77 (br. s, 1H14), 4.25 (q, J = 7.3 Hz, 2H5), 3.82 (s, 3H19), 1.56 (t, J = 
7.3 Hz, 3H6).13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 184.9 (C=O), 156.2 (C-OMe), 147.3 (C=C), 
141.4 (C-NH), 136.8 (C-N), 134.3 (C-NH), 133.4 (CH), 130.1 (CH), 127.2 (CH(N)), 126.4 (CH), 123.7 
(CH), 123.5 (CH), 123.3 (C=C), 122.6 (CH), 114.9 (C(C=O)), 114.8 (CH), 109.8 (CH), 55.7 (OCH3), 41.9 
(CH2), 15.4 (CH3(CH2).
7a HRMS (ESI/Q-TOF) m/z: [M+H]+ Calcd for C26H24N2O2 397.1916. Found: 397.1910
7b HRMS (ESI/Q-TOF) m/z: [M+H]+ Calcd for C26H24N2O2 397.1916. Found: 397.1910
Compound 7c
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N
O
N
H1
H2
H3
H4 H5
H5
H6H6 H6
H7
H8
H9
H10
H13
H11
H12
O
H14
H14
H15
H15
H16
H16
H17
H17
Following the general procedure, from N-Et-Indenone (17.60 mg, 0.05 mmol) and morpholine (4.80 
mg, 0.05 mmol), the product was obtained in 74% (13.40 mg) as an orange/brown oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = 8.41 (m, 1H1), 7.78 (d, J = 30.0 Hz, 1H7), 7.38 (m, 2H8 and 9), 7.31 
(m, 3H2,11 and 12), 7.19 (d, J = 8.4 Hz, 2H3 and 4), 6.87 (d, J = 8.5 Hz, 2H10 and 13), 4.22 (m, 2H5), 4.23-4.18 
(m, 2H15 and 16), 3.87-3.82 (m, 2H14 and 17), 3.17 (m, 4H14 and 17; 15 and 16), 1.25 (s, 3H6).
13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = 194.9 (C=O), 193.2 (C-N), 149.7 (C=C), 136.7 (C-N), 134.2 
(CH), 133.7 (CH), 133.6 (C), 129.2 (CH), 126.6 (C), 124.8 (CH), 123.3 (CH), 122.9 (C=C), 122.7 (CH), 
117.2 (C), 116.7 (CH), 116.2 (CH), 109.8 (CH), 67.1 (CH2), 49.8 (CH2), 42.1 (CH2), 41.9 (CH2), 41.8 (CH2), 
15.3 (CH3).
HRMS (ESI/Q-TOF) m/z: [M+H]+ Calcd for C23H24N2O2 361.1916. Found: 361.1916.
6. Optimization of the ketone arylation
General procedure: A vial was charged with the pre-catalyst, base, solvent (1 mL) and a 
magnetic stir bar and sealed with a screw cap. The mixture was let to stir at 60 °C for 1 h. 
The sample was removed from the heating block and the corresponding aryl ketone was 
added followed by the corresponding aryl chloride. The reaction was left to stir (910 rpm) at 
80 °C for 3 h.
6.1. Catalyst Screening
The general procedure was followed using propiophenone (74 mg, 0.55 mmol), 4-
chloroanisole (63 mg, 0.5 mmol) with NaOtBu (53 mg, 0.55 mmol) in CPME (1 mL). 
Table S13: Pre-catalyst optimisation using 0.20 mol%
O
+
Cl
[Pd] 0.2 mol%
NaOtBu (1.1 equiv.)
CPME, 80 °C, 3 h
0.55 mmol0.5 mmol
O
Entries Pd Pre-catalyst GC conversion (%)a
1 [IPent·H][Pd(ƞ3-cin)Cl2] 99
2 [IHept·H][Pd(ƞ3-cin)Cl2] 99
3 [IPr*·H][Pd(ƞ3-cin)Cl2] 99
4 [Pr*OMe·H][Pd(ƞ3-cin)Cl2] 99
5 [IPr*·H][Pd(ƞ3-crotyl)Cl2] 94
6 [IPr*·H][Pd(ƞ3-2-Me-allyl)Cl2] 99
a GC conversion based on 4-chlorotoluene. Value calculated from an average of two reactions.
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Table S14: Pre-catalyst optimization using 0.1 mol%
O
+
Cl
[Pd] 0.1 mol%
NaOtBu (1.1 equiv.)
CPME, 80 °C, 3 h
0.55 mmol0.5 mmol
O
Entries Pd Pre-catalyst GC conversion (%)a
1 [IPent·H][Pd(ƞ3-cin)Cl2] 83
2 [IHept·H][Pd(ƞ3-cin)Cl2] 77
3 [IPr*·H][Pd(ƞ3-cin)Cl2] 86
4 [Pr*OMe·H][Pd(ƞ3-cin)Cl2] 72
5 [IPr*·H][Pd(ƞ3-2-Me-allyl)Cl2] 79
a GC conversion based on 4-chlorotoluene. Value calculated from an average of two reactions.
6. 2. Base/Solvent screening
The general procedure was followed using [IPr*·H][Pd(ƞ3-cin)Cl2] (1.2 mg, 0.001 mmol), 
propiophenone (74 mg, 0.55 mmol) and  4-chloroanisole (63 mg, 0.5 mmol). 
Table S15: Base optimization using cyclopentylmethyl ether (CPME)
O
+
Cl
[Pd] 0.2 mol%
Base (1.1 equiv.)
Solvent, 80 °C, 3 h
0.55 mmol0.5 mmol
O
Entries Base (0.55 mmol) GC conversion (%)
1 KOtBu n.r.
2 LiOtBu 31
3 NaOtBu 99
4 KOH n.r.
5 NaOH n.r.
GC conversion based on 4-chlorotoluene. Value calculated from an average of two reactions.
Table S16: Base optimization using toluene
O
+
Cl
[Pd] 0.2 mol%
Base (1.1 equiv.)
Solvent, 80 °C, 3 h
0.55 mmol0.5 mmol
O
Entries Base (0.55 mmol) GC conversion (%)
1 KOtBu 72
2 LiOtBu 5
3 NaOtBu 91
4 KOH n.r
5 NaOH n.r
GC conversion based on 4-chlorotoluene. Value calculated from an average of two reactions.
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Table S17: Base optimization using THF
O
+
Cl
[Pd] 0.2 mol%
Base (1.1 equiv.)
Solvent, 80 °C, 3 h
0.55 mmol0.5 mmol
O
Entries Base (0.55 mmol) GC conversion (%)
1 KOtBu n.r.
2 LiOtBu traces
3 NaOtBu 31
4 KOH n.r.
5 NaOH n.r.
GC conversion based on 4-chlorotoluene. Value calculated from an average of two reactions.
Table S18: Base optimization using 1,4-dioxane
O
+
Cl
[Pd] 0.2 mol%
Base (1.1 equiv.)
Solvent, 80 °C, 3 h
0.55 mmol0.5 mmol
O
Entries Base (0.55 mmol) GC conversion (%)
1 KOtBu 11
2 LiOtBu n.r.
3 NaOtBu 11
4 KOH n.r.
5 NaOH n.r.
GC conversion based on 4-chlorotoluene. Value calculated from an average of two 
reactions.
7. Scope
General procedure: A vial was charged with [IPr*·H][Pd(ƞ3-cin)Cl2] (1.2 mg, 0.2 mol%), 
NaOtBu (53 mg, 0.55 mmol), CPME (1 mL) and a magnetic stir bar and sealed with a screw 
cap. The mixture was let to stir at 60 °C for 1 h. The vial was removed from the heating block 
and the corresponding solution of aryl ketone and aryl chloride in CPME (1 mL) was added. 
The reaction was left to stir (910 rpm) for 1-3 h at 80 °C. The reaction was purified using 
flash chromatography, 5:95 ethyl acetate/petroleum ether.
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Compound 10a
O
Chemical Formula: C16H16O
Molecular Weight: 224.30
Following the general procedure, from 4-chlorotoluene (63 mg, 0.5 mmol) and 
propiophenone (74 mg, 0.55 mmol), the product yielded 111 mg (99 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.96 (dd, J = 8.4, 1.3 Hz, 2H), 7.49 (tt, J = 7.4 Hz, 1H), 
7.39 (tt, J = 7.5 Hz, 2H), 7.18 (dt, J = 8.1 Hz, 2H), 7.11 (d, J = 7.9 Hz, 2H), 4.55 (q, J = 6.8 Hz, 
1H), 2.28 (s, 3H), 1.51 (d, J = 6.8 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 200.4 
(C=O), 138.3 (C), 136.4 (C), 136.4 (C), 132.6 (CH), 129.6 (CH), 128.7 (CH), 128.3 (CH), 127.5 
(CH), 47.4 (CH), 20.9 (CH3), 19.4 (CH3).
Analytical data obtained were in agreement with the reported values.12
Compound 10b
O
OMe
Chemical Formula: C16H16O2
Molecular Weight: 240.30
Following the general procedure, from 4-chloroanisole (72 mg, 0.5 mmol) and 
propiophenone (74 mg, 0.55 mmol), the product yielded 117.4 mg (98 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.98 (d, J = 7.1Hz, 2H), 7.48 (t, J = 7.4 Hz, 1H), 7.40 (t, 
J = 7.6 Hz, 2H), 7.23 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 4.68 (q, J = 6.8 Hz, 1H), 3.74 (s, 
3H), 1.53 (d, J = 6.9 Hz, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 200.6 (C=O), 158.5 
(C), 136.5 (C), 133.5 (C), 132.8 (CH), 128.8 (CH), 128.8 (CH), 128.5 (CH), 114.4 (CH), 55.2 
(CH3), 47.0 (CH), 19.6 (CH3).
Analytical data obtained were in agreement with the reported values.12
Compound 10c
O
CF3
Chemical Formula: C16H13F3O
Molecular Weight: 278.27
Following the general procedure, from 4-chlorobenzotrifluride (90.3 mg, 0.5 mmol) and 
propiophenone (74 mg, 0.55 mmol), the product yielded 134.7 mg (97 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 7.96 (d, J = 7.5 Hz, 2H), 7.57 (d, J = 8.1 Hz, 2H), 7.53 
(t, J = 7.4 Hz, 1H), 7.43 (m, 4H), 4.80 (q, J = 6.9 Hz, 1H), 1.57 (d, J = 6.9 Hz, 3H). 13C {1H} NMR 
(100 MHz, CDCl3): δ (ppm) = δ 199.8 (C=O), 145.5 (C), 136.2 (C), 133.3 (CH), 129.3 (q, C(CF3), 
J = 32.5 Hz), 128.8 (CH), 128.8 (CH), 128.3 (CH), 126.0 (q, CH, J = 3.6 Hz), 125.3 (q, CF3, J = 
272.0 Hz), 47.6 (CH), 19.5 (CH3).
 Analytical data obtained were in agreement with the reported values.12
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Compound 10d
O
OMe
Chemical Formula: C17H16O2
Molecular Weight: 252.31
Following the general procedure, from 4-chloroanisole (71 mg, 0.5 mmol) and α-tetralone 
(73.1 mg, 0.55 mmol), the product yielded 88.5 mg (70 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.18 (d, J = 9.0 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.40 (t, 
J = 7.6 Hz, 1H), 7.22 (m, 3H), 6.81 (d, J = 8.9 Hz, 2H), 4.13 (s, 1H), 3.75 (s, 3H), 2.94 (m, 1H), 
2.76 (m, 2H), 2.47-2.40 (m, 1H). 13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 201.0 (C=O), 
159.5 (C), 144.4 (C), 134.3 (CH), 132.9 (C), 131.8 (C), 129.2 (CH), 127.8 (CH), 127.6 (CH), 
127.1 (CH), 114.1 (CH), 77.5 (CH), 55.4 (CH3), 36.5 (CH2), 26.8 (CH2).
Analytical data obtained were in agreement with the reported values.13
Compound 10e
O
OMe
Chemical Formula: C17H16O2
Molecular Weight: 252.31
Following the general procedure, from 2-chloroanisole (71 mg, 0.5 mmol) and α-tetralone 
(73.1 mg, 0.55 mmol), the product yielded   mg (70 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.12 (d, J = 7.8 Hz, 1H), 7.52 (t, J = 7.5 Hz, 1H), 7.36 (t, 
J = 7.5 Hz, 1H), 7.30 (m, 2H), 7.13 (d, J = 9.1 Hz, 1H), 6.96 (dd, J = 17.4, 7.9 Hz, 2H), 4.08 (dd, J 
= 12.3, 4.7 Hz, 1H), 3.76 (s, 3H), 3.18-3.14 (m, 1H), 3.04-3.01 (m, 1H), 2.55 (qd, J = 27.2, 14.3 
Hz, 1H), 2.30-2.26 (m, 1H). 13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 198.3 (C=O), 157.2 
(C), 144.2 (C), 133.2 (CH), 129.5 (C + CH), 129.3 (C), 128.8 (CH), 128.3 (CH), 127.8 (CH), 126.7 
(CH), 120.9 (CH), 111.2 (CH), 55.6 (CH3), 50.1 (CH), 30.0 (CH2), 29.6 (CH2).
Analytical data obtained were in agreement with the reported values.14
Compound 10f
Chemical Formula: C17H16O
Molecular Weight: 236.31
O
Following the general procedure, from 4-chlorotoluene (63.3 mg, 0.5 mmol) and α-tetralone 
(73.1 mg, 0.55 mmol), the product yielded 112 mg (95 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.18 (dd, J = 7.8, 0.8 Hz, 1H), 7.53 (t, J = 8.1 Hz, 1H), 
7.40 (t, J = 7.6 Hz, 1H), 7.20 (m, 3H), 7.09 (d, J = 8.1 Hz, 2H), 4.17 (s, 1H), 2.93 (m, 1H), 2.77 
(m, 2H), 2.47-2.41 (m, 1H), 2.29 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 201.0 
(C=O), 144.4 (C), 138.1 (C), 137.9 (C), 134.3 (C), 131.8 (CH), 129.4 (CH), 129.2 (CH), 127.8 
(CH), 127.1 (CH), 126.2 (CH), 77.7 (CH), 36.5 (CH2), 26.8 (CH2), 21.2 (CH3).
Analytical data obtained were in agreement with the reported values.15
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Compound 10g
O
OMe
Chemical Formula: C15H14O2
Molecular Weight: 226.28
Following the general procedure, from 4-chlorotoluene (63.3 mg, 0.5 mmol) and 
acetophenone (60 mg, 0.55 mmol), the product yielded 110 mg (98 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.08 (d, J = 7.1 Hz, 2H), 7.57 (t, J = 6.8 Hz, 1H), 7.48 (t, 
J = 7.7 Hz, 2H), 7.30 (t, J = 8.7 Hz, 1H), 7.22 (d, J = 8.9 Hz, 1H), 6.97 (t, J = 7.4 Hz, 1H), 6.92 (d, 
J = 8.2 Hz, 1H), 4.31 (s, 2H), 3.80 (s, 3H).13C {1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 198.0 
(C=O), 157.2 (C), 137.0 (C), 133.0 (CH), 131.1 (CH), 128.6 (CH), 128.5 (CH), 128.4 (CH), 123.7 
(C), 120.7 (CH), 110.6 (CH), 55.4 (CH3), 40.1 (CH2).
Analytical data obtained were in agreement with the reported values.14
Compound 10h
O
Chemical Formula: C16H16O
Molecular Weight: 224.30
Following the general procedure, from 2-chloro,1-3-dimethylbenzene (70 mg, 0.5 mmol) 
and acetophenone (60 mg, 0.55 mmol), the product yielded 105  mg (95 %) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.12 (d, J = 7.4 Hz, 2H), 7.64 (t, J = 7.0 Hz, 1H), 7.55 (t, 
J = 7.3 Hz, 2H), 7.14 (m, 3H), 4.40 (s, 2H), 2.24 (s, 6H).13C {1H} NMR (100 MHz, CDCl3): δ 
(ppm) = δ 197.0 (C=O), 137.2 (C), 137.1 (C), 133.3 (CH), 132.5 (C), 128.8 (CH), 128.2 (CH), 
128.1 (CH), 127.0 (CH), 39.7 (CH2), 20.5 (CH3).
Analytical data obtained were in agreement with the reported values.16
Compound 10i
O
OMe
Chemical Formula: C15H14O2
Molecular Weight: 226.28
Following the general procedure, from 4-chloroanisole (72 mg, 0.5 mmol) and 
acetophenone (60 mg, 0.55 mmol), the product yielded  110 mg (97 %) as a yellow oil.
1H NMR (400 MHz, CDCl3): δ (ppm) = δ 8.03-8.01 (m, 2H), 7.58 (tt, J = 7.2, 1.3 Hz, 1H), 7.48 
(tt, J = 6.8, 1.3 Hz, 2H), 7.20-7.18 (m, 2H), 6.89-6.86 (m, 2H), 4.23 (s, 2H), 3.79 (s, 3H). 13C 
{1H} NMR (100 MHz, CDCl3): δ (ppm) = δ 198.0 (C=O), 158.6 (C), 136.7 (C), 133.2 (CH), 130.6 
(CH), 128.7 (CH), 128.7 (CH), 126.6 (C), 114.3 (CH), 55.3 (CH3), 44.7 (CH2).
Analytical data obtained were in agreement with the reported values.15
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8. NMR spectra: 1H and 13C {1H}, CDCl3 (solvent signal at 7.26 
ppm)
8.1. Palladates
IPent·H][Pd(ƞ3-cin)Cl2]: 1H NMR
 [IPent·H][Pd(ƞ3-cin)Cl2]: 13C {1H} NMR
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N N
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Et
Et
Et
Et
H
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 [IHept·H][Pd(ƞ3-cin)Cl2]: 1H NMR
Pd
Cl Cl
N N
PrPr Pr Pr
Pr
Pr
Pr
Pr
H
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 [IHept·H][Pd(ƞ3-cin)Cl2]: 13C {1H} NMR
S29
 [INon·H][Pd(ƞ3-cin)Cl2]: 1H NMR
 [INon·H][Pd(ƞ3-cin)Cl2]: 13C {1H} NMR
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Bu
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 [IPr*·H][Pd(ƞ3-cin)Cl2]: 1H NMR
 [IPr*·H][Pd(ƞ3-cin)Cl2]: 13C {1H} NMR
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Ph
Ph
Ph
Ph
H
S31
 [IPr*OMe·H][Pd(ƞ3-cin)Cl2]: 1H NMR
 [IPr*OMe·H][Pd(ƞ3-cin)Cl2]: 13C {1H} NMR
Pd
Cl Cl
N N
PhPh Ph Ph
Ph
Ph
Ph
Ph
H
MeO OMe
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 [IPentCl·H][Pd(ƞ3-cin)Cl2]: 1H NMR
 [IPentCl·H][Pd(ƞ3-cin)Cl2]: 13C {1H} NMR
Pd
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N N
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Et
Et
Et
H
Cl Cl
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 [IPr*·H][Pd(ƞ3-crotyl)Cl2]: 1H NMR
 [IPr*·H][Pd(ƞ3-crotyl)Cl2]: 13C {1H} NMR
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S34
 [IPr*·H][Pd(ƞ3-2-Me-allyl)Cl2]: 1H NMR
 [IPr*·H][Pd(ƞ3-2-Me-allyl)Cl2]: 13C {1H} NMR
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Ph
Ph
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 [IPr*·H][Pd(IndtBu)Cl2]: 1H NMR
 [IPr*·H][Pd(IndtBu)Cl2]: 13C {1H} NMR
Pd
Cl Cl
N N
PhPh Ph Ph
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H
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8.2 Cross coupling products
Compound 4a: 1H NMR
Compound 4a: 13C {1H} NMR
H
N
F OMe
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Compound 4b: 1H NMR
H
NF
OMe
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Compound 4b: 13C {1H} NMR
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Compound 4c: 1H NMR
Compound 4c: 13C {1H} NMR
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Compound 4d: 1H NMR
Compound 4d: 13C {1H} NMR
H
N
MeO
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Compound 4e: 1H NMR
 Compound 4e: 13C {1H} NMR 
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H
N
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Compound 4f: 1H NMR
Compound 4f: 13C {1H} NMR
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Compound 4g: 1H NMR
Compound 4g: 13C {1H} NMR 
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N
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Compound 4h: 1H NMR
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Compound 4i: 1H NMR
Compound 4i: 13C {1H} NMR
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Compound 4j: 1H NMR
Compound 4j: 13C {1H} NMR
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N
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Compound 4k: 13C {1H} NMR
Compound 4k: 1H NMR
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Compound 4l: 1H NMR
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Compound 4m : 1H NMR
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Compound 4n : 1H NMR
Compound 4n : 13C {1H} NMR
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Compound 4o : 1H NMR
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Compound 4o : 13C {1H} NMR
Compound 5a : 1H NMR
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Compound 5b : 1H NMR
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Compound 5b : 13C {1H} NMR
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Compound 5c : 1H NMR
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Compound 5d : 1H NMR
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Compound 5e : 1H NMR
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Compound 5f: 1H NMR
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Compound 5g : 1H NMR
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Compound 5h : 1H NMR
Compound 5h : 13C {1H} NMR
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Compound 5i: 1H NMR
OMe
N
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Compound 5i: 13C {1H} NMR
 (E)-3-(4-chlorophenyl)-1-(1-ethyl-1H-indol-3-yl)prop-2-en-1-one (6a) : 1H NMR
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 (E)-3-(4-chlorophenyl)-1-(1-ethyl-1H-indol-3-yl)prop-2-en-1-one (6a) : 13C {1H} NMR
N
O Cl
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 (E)-3-(4-bromophenyl)-1-(1-ethyl-1H-indol-3-yl)prop-2-en-1-one (6b) : 1H NMR
 (E)-3-(4-bromophenyl)-1-(1-ethyl-1H-indol-3-yl)prop-2-en-1-one (6b) : 13C {1H} NMR
N
O Br
S65
Compounds 7a and 7b : 1H NMR
Compounds 7a and 7b : 13C {1H} NMR
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Compound 7c : 1H NMR
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Compound 10a : 1H NMR
Compound 10a : 13C {1H} NMR
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Compound 10b : 1H NMR
Compound 10b : 13C {1H} NMR
O OMe
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Compound 10c: 1H NMR
O CF3
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Compound 10c: 13C {1H} NMR
Compound 10d : 1H NMR
O OMe
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 Compound 10d : 13C {1H} NMR
Compound 10e : 1H NMR
O
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Compound 10e : 13C {1H} NMR
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Compound 10f : 1H NMR
Compound 10f : 13C {1H} NMR
O
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Compound 10g : 1H NMR
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Compound 10h : 1H NMR 
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Compound 10i : 1H NMR
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